The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 78 | 10.1x | 20.1x | Above average | |
Growth | 28 | -1.4% | 5.6% | Below average | |
Quality | 59 | 15.0% | 7.6% | Near average | |
Safety | 68 | -1.0x | 0.4x | Above average | |
Capital Return | 66 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Amphastar Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Amphastar Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
AMPH stock has seen a significant decline in its average price target by 10.87% over the past 30 days, as the consensus dropped from 23 dollars to 20.5 dollars. This negative adjustment reflects a decline in analyst optimism, especially with a narrow gap between the high (22 dollars) and low (19 dollars) estimates, indicating an agreement among the remaining analysts on a lower valuation for the stock compared to previous periods.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.